TITLE

Maintenance of physiological coronary endothelial function after 3.3 h of hypothermic oxygen persufflation preservation and orthotopic transplantation of non-heart-beating donor hearts

AUTHOR(S)
H. Fischer, Jürgen; Funcke, Claudia; Yotsumoto, Goichi; Jeschkeit-Schubbert, Stephanie; Kuhn-Régnier, Ferdinand
PUB. DATE
January 2004
SOURCE
European Journal of Cardio-Thoracic Surgery;Jan2004, Vol. 25 Issue 1, p98
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: The use of non-heart-beating donors (NHBD) might increase the number of grafts available for transplantation. Experiments on heart transplantation from NHBDs demonstrated the necessity for oxygenation during preservation to allow sufficient myocardial recovery. It has been shown that, after 16 min normothermic ischemia followed by 3.3-h hypothermic preservation, excellent myocardial and cardiovascular recovery is attained, if coronary oxygen persufflation (COP) is included in the preservation protocol. Here tests are presented on the recovery of coronary endothelium derived relaxation (EDR) of NHBD hearts after preservation including COP. Methods: After 16 min normothermic ischemia, pig hearts were stored for 3.3 h at 0–1 °C in modified HTK plus COP (mBHTK+COP, n=6) or in two control groups without COP: (1) with mBHTK (n=6); and (2) with HTK (n=4). Following orthotopic transplantation and 3 h of reperfusion with full blood, coronary EDR was tested in vitro using Substance P (SP) under indomethacin for prostaglandin blockage. Additional tests were performed adding l-NIL to block the NO-production by iNOS or l-NNA to block total NO production. Results: The EDR in percent of precontraction was 78±7% after mBHTK+COP and 77±20% (mBHTK) or 72±7% (HTK) in the controls without significant differences between the groups. Physiologic values of normal coronaries were 75±9%. l-NIL for blockage of NO-production by iNOS resulted in unchanged relaxations. After blockage of total NO production by l-NNA, the SP-induced dilation was significantly reduced to 58±8% (mBHTK+COP) and to 48±8% (mBHTK) or 55±13% (HTK) in the controls. Conclusions: Even after 16 min of warm ischemia followed by 3.3 h of preservation with gaseous oxygen persufflation, orthotopic transplantation, and reperfusion the endothelium derived coronary dilatation was unchanged from physiologic values and similar to the controls without COP. Blockage of NO production by l-NNA resulted in equal values of EDR with or without COP, while blockage of NO production by iNOS did not influence the EDR reaction. Thus COP preservation, which has been shown to allow excellent recovery of preserved NHBD hearts, caused no damage to the coronary EDR mechanisms.
ACCESSION #
11733144

 

Related Articles

  • IMAGES IN CARDIOLOGY: Heterotopic heart transplantation: three dimensional image. Grande, A. M.; Monterosso, C.; Dore, R.; Viganò, M. // Heart;Sep2005, Vol. 91 Issue 9, p1172 

    This article presents a case of heterotopic heart transplantation in a 47 year old man who had post-ischaemic dilated cardiomyopathy. The patient presented with an anterior myocardial infarction (MI) in 1989 and an inferior MI seven years later. In March 1997, the patient underwent double...

  • Orthotopic heart transplantation with donors greater than or equal to 60 years of age: a single-center experience Bruschi, Giuseppe; Colombo, Tiziano; Oliva, Fabrizio; Morici, Nuccia; Botta, Luca; Cannata, Aldo; Frigerio, Maria; Martinelli, Luigi // European Journal of Cardio-Thoracic Surgery;Jul2011, Vol. 40 Issue 1, pe55 

    Abstract: Objectives: Heart transplantation is the best therapeutic option for patients suffering from end-stage heart failure, but donor organ availability still represents a major problem. This had led to a shift toward extended donor criteria. The aim of the present study is to analyze the...

  • Guillain-Barré Syndrome due to CMV Reactivation after Cardiac Transplantation. Steger, Christina Maria; Antretter, Herwig; Höfer, Daniel // Case Reports in Cardiology;2012, p1 

    A 40-year-old male patient suffered from end-stage heart failure due to ischemic cardiomyopathy and received orthotopic cardiac transplantation in June 2005. The instantaneous postoperative course was uneventful, but, seven months later, he suffered from paralysis in the lower extremities...

  • Coronary artery–pulmonary artery fistula in a heart-transplanted patient. Vermeulen, Tom; Haine, Steven; Paelinck, Bernard P.; Rodrigus, Inez E.; Vrints, Christiaan J.; Conraads, Viviane M. // European Journal of Echocardiography;Jan2010, Vol. 11 Issue 1, p80 

    A 64-year-old-man underwent routine elective right-left heart catheterization, 1 year after cardiac transplantation for terminal ischaemic cardiomyopathy. Surprisingly, selective coronary angiography disclosed coronary–pulmonary artery fistula with three feeding vessels originating from...

  • To the heart of the matter. HILSENBECK, KIM // Hays Free Press (Buda, TX);9/11/2013, Vol. 111 Issue 23, p1C 

    The article focuses on Landon Tyner, a 15-year old from Buda, Texas who has dilated cardiomyopathy and is awaiting for a heart transplant at the Texas Children's Hospital in Houston.

  • Could you have saved my life? Levine, Hallie // Glamour;Mar2003, Vol. 101 Issue 3, p206 

    Relates experience of a familial dilated cardiomyopathy patient. Death of her mother from the same disease; Contribution of a heart transplant on the patient; Call for organ donors to save other people's lives.

  • Long term outcome in patients with end-stage ischemic dilated cardiomyopathy after heart transplantation or surgical ventricular restoration. Triggiani, M.; Trunfio, S.; Sebastiani, R.; Pentiricci, S.; Parrella, P.; Gamba, A.; Gavazzi, A.; Ferrazzi, P. // European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 1, p199 

    An abstract of the article "Long term outcome in patients with end-stage ischemic dilated cardiomyopathy after heart transplantation or surgical ventricular restoration," by M. Triggiani is presented.

  • Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. Kärkkäinen, S.; Reissell, E.; Heliö, T.; Kaartinen, M.; Tuomainen, P.; Toivonen, L.; Kuusisto, J.; Kupari, M.; Nieminen, M. S.; Laakso, M.; Peuhkurinen, K. // Heart;Apr2006, Vol. 92 Issue 4, p524 

    The article investigates the mutations in the lamin A/C gene in a group of Finnish heart transplant recipients with end stage dilated cardiomyopathy in Finland. Participants of the study include all surviving Finnish patients who received a heart transplant between 1984 and 1998. This study is...

  • Dr. Kirk Kanter.  // Atlanta;Jul2009, Vol. 49 Issue 3, p68 

    The article focuses on the achievements of pediatric cardiothoracic surgeon Kirk Kanter from Atlanta, Georgia. It describes how Kanter implanted a Berlin heart on Yasir Yesuf, a three months old patient diagnosed with cardiomyopathy. According to Kanter, who is director of the heart transplant...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics